Clinical trial
A Matched Cohort Study of Regranex (Becaplermin) and the Risk of Cancer
NCT00518102 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Matched Cohort Study of Regranex (Becaplermin) and the Risk of Cancer
- Lead sponsor
- Ethicon, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- May 31, 2005
- Enrollment
- 4,431 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.